MeSH Browser

MeSH Heading: Epoetin Alfa
Tree Number(s): D12.644.276.374.410.240.150.500; D12.776.395.240.150.750; D12.776.467.374.410.240.150.500; D23.529.374.410.240.150.750
Unique ID: D000068817
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068817
Scope Note: A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
Entry Term(s): Binocrit; Epoetin Alfa Hexal; Epogen; Eprex; HX575; HX575 Compound; Heberitro; Procrit; Recombinant 1-165 Erythropoietin, Glycoform Alpha
Pharm Action: Hematinics
Registry Number: 64FS3BFH5W
Related Numbers: 113427-24-0
CAS Type 1 Name: 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha
Public MeSH Note: 2016; EPOETIN ALFA was indexed under ERYTHROPOIETIN 2011-2015
History Note: 2016 (2011)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2015/06/16

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Epoetin Alfa MeSH Descriptor Data 2023